Cancer & Carcinogens Part 1 - Four Common Cancer-Causing Substances & Your Exposure
Cancer & Carcinogens Part 1 - Four Common Cancer-Causing Substances & Your Exposure What substances in the environment are known to cause or are ...
Safety Memos
Nitrosamines risk assessment: why?
This is the first video of a series which will summarize how the risk assessment for nitrosamines in drug products should be done. Since 2018, many batches of ...
Fernanda Waechter
MDR/IVDR – How MedPharmPlast is helping overcoming the potential challenges
MDR/IVDR makes it essential for OEMs to understand what substances are in their devices. This pattern is repeated in impending USP regulations to use ...
Nelson Labs
“Chemical Carcinogenesis and Cancer Preventive Effects of Anticarcinogenic Foods”
TÜBA Şeref Üyesi ve ODTÜ, Fen Edebiyat Fakültesi, Biyolojik Bilimler Bölümü Öğretim Üyesi Prof. Dr. Emel Arınç TÜBA Üniversite Konferansları Programı ...
Türkiye Bilimler Akademisi
Webinar I VaporFuse: improved MJF part properties - green & industrial
For a long time, chemical smoothing has been associated with harsh chemicals, toxic waste, and single-use solvents. The Powerfuse S using our proprietary ...
DyeMansion GmbH
Enquête | The Monsanto papers: The Canadian Connection
Originally aired on Enquête in French on February 21, 2019 The Monsanto Papers are secrect company documents that show disturbing practices used to ...
Radio-Canada Info
How to avoid the next nitrosamine crisis: 5 lessons learned about impurity detection
In this webinar, we cover key analytical tests, how to improve methods and gain more information about your samples, and how Waters analytical expertise can ...
Waters Corporation
ILSI NA: IAFP 2014 – Introduction to Threshold of Toxicological Concern (TTC) (Mitch Cheeseman)
Threshold of Toxicological Concern (TTC) – A Pragmatic Approach to Determine the Risk of a Chemical Substance of Unknown Toxicity Sponsored by the ILSI ...
ILSI Global
Overview of Non-clinical Assessment in Drug Development (8/14) REdI 2017
Hanan Ghantous covers the role and responsibilities of the pharmacology/toxicology reviewer related to the various components of the Investigational New Drug ...
U.S. Food and Drug Administration
Questions and Answers (23of28) Generic Drugs Forum – Apr. 3-4, 2019
Presenters Nusie Motlekar, Frank Holcombe, Om Anand, Hongbio Liao, and Victoria Keck answer audience questions. Learn more at ...
U.S. Food and Drug Administration
Using Geographic Patterns to Discover Environmental Carcinogens
In May 2014, NCI's Division of Cancer Epidemiology and Genetics (DCEG) hosted “Cancer Epidemiology: From Pedigrees to Populations,” a scientific ...
National Cancer Institute
The Monsanto Papers : Roundup & The Canadian Connection - Enquête
Monsanto has faced claims its popular weedkiller Roundup may cause cancer, after the World Health Organization's International Agency for Research on ...
CBC News
ISO 10993-18 in the MDR: understanding the restrictions & risk assessment for different compounds
This presentation explains to what extent a chemical characterization study (ISO 10993-18) can assist in meeting the requirements of section 10.4 of the MDR.
Nelson Labs
Selected Case Studies and Impurity Strategies for Drug Substances by Paul Wrezel, Ph.D. (Full)
Regis' Director of Analytical Method Development, Dr. Paul Wrezel, repurposes his Pittcon 2015 talk for a Regis audience. This is the full talk and covers ...
Regis Technologies, Inc.
Impurity Case Studies: Pharmacology/Toxicology (22of28) Generic Drugs Forum – Apr. 3-4, 2019
CDER's Office of Pharmaceutical Quality's Hongbio Liao and Office of Generic Drugs' Victoria Keck discuss impurities. A top RTR is due to impurity issues.
U.S. Food and Drug Administration
J. Michael Bishop (UCSF) Part 1: Forging a genetic paradigm for cancer
http://www.ibiology.org/ibioseminars/cancer-medicine/j-michael-bishop-part-1.html Bishop begins his lecture with a historical review of the experiments that ...
iBiology
Dr. Becker Interviews Dr. Turesky
http://healthypets.mercola.com/sites/healthypets/archive/2013/05/27/cooked-meat-carcinogens.aspx Dr. Karen Becker, a proactive and integrative wellness ...
MercolaHealthyPets
The Need for Pharmacovigilance
Handouts available here: https://bit.ly/2NOdlIM Speaker: Sten Olsson (2011) This session gives you the scope and definition of what pharmacovigilance is today.
Uppsala Monitoring Centre
Risk assessment of potentially mutagenic impurities in drug products approved in Brazil
A partnership between the University of Sao Paulo and Ache Laboratorios to study potentially mutagenic impurities in drug products approved in Brazil - watch ...
Fernanda Waechter
Drug Substance Quality Assessment: Best Practices (23of27) Generic Drugs Forum 2018
CDER Office of Pharmaceutical Quality's Ramnarayan Randad covers new features of GDUFA II such as enhanced mechanisms to facilitate communication, first ...
U.S. Food and Drug Administration
What Manufacturers Need to Know about the Updated ISO 10993-1 and New ISO 21726
The approach expected by regulators for evaluation of medical device biocompatibility has been rapidly changing as expectations within regulatory bodies has ...
Nelson Labs
Drug Development and FDA Review Process
Michigan Alzheimer's Disease Center
A Year of EU MDR Remediation: Biocompatibility Strategies and Lessons Learned
Enforcement of the EU MDR was scheduled for May 2020, which would require all submissions for CE marking or renewal to comply with the new regulation.
Nelson Labs
Genotoxic Impurities (4 of 4)
This a video of a seminar titled, Safety Evaluation of Impurities, by Michael Schlosser, PhD presented in February, 2014 at Regis Technologies inc., Morton ...
Regis Technologies, Inc.
Biocomaptibility and the New MDR
This presentation will include an overview of biocompatibility in compliance with the new MDR. The key focus will be on highlighting differences on previous ...
Nelson Labs
Occupational Cancer webinar
The TUCs Hugh Robertson discusses what unions can do to reduce workers' exposure to carcinogens.
TUC Education
Toxicology and Risk Assessment MSc webinar | Thursday 10 March
This is a recording of the presentation and slides used for the Toxicology MSC webinar.
Brunel University London
In vitro strategies for regulatory genotoxicity testing
Genotoxicity testing requirements can vary across industries and stages of development. In this presentation, our in vitro genotoxicity experts discuss strategies ...
Cyprotex Discovery
UDI in the EU MDR – How different is it from the US FDA?
In this webinar on "UDI in the EU MDR – How different is it from the US FDA?", speaker Lena Cordie, focuses on comparing the similarities and differences ...
Argos Multilingual
WHO classifies bacon, sausage, and other processed meats as group 1 carcinogen
The World Health Organization classified bacon, ham, and other processed meats as a group 1 carcinogen putting it in the same category as smoking.
民視英語新聞 Formosa TV English News
Micro Lesson 10: Tools for Characterizing DNA, RNA, Proteins, Genetic Engineering & Gene Therapy
Jump to Topics: 0:20 Learning Objectives 1:10 Mutations 8:15 Microbes and the Tools of Genetic Engineering 13:50 Visualizing and Characterizing DNA, RNA ...
Professor Simms
Changes to ISO10993-1 and relationship to Medical Device Regulation
Presenter: Henry Sibun The 2018 revision of ISO 10993-1 goes hand-in-hand with the MDR to give clear and more detailed guidance on what is required.
Nelson Labs
Nitrosamines risk assessment: step 2
In the previous videos, we explained what are nitrosamines and how to perform the risk assessment of their presence in drug products. And when a potential risk ...
Fernanda Waechter
INDUSTRIAL WATER POLLUTION
Subject: Chemistry Course: Environmental Chemistry Keyword: SWAYAMPRABHA.
CH-08:ARYABHATT [Mathematics, Physics, Chemistry]
The Future of 10993 and the Proposed ISO 10993 Changes for Hemocompatibility and Genotoxicity
An overview of the testing in ISO 10993-4: Selection of tests for interactions with blood and ISO 10993-3: Tests for genotoxicity, carcinogenicity and reproductive ...
Nelson Labs
Tox 21 and Toxicological Testing for Home, Institutional and Personal Care
Tox 21 stands for toxicity testing in the 21st century. What it signifies is the transformation that is occurring in the field of toxicology today where the reliance on ...
Dow
What is a Carcinogen
What is a carcinogen?
WorldBookNetwork
[Webinar] Preparing for the New EU Medical Device Regulation
The upcoming European Union (EU) Medical Device Regulation (MDR) will replace the Medical Devices Directive and the Active Implantable Medical Devices ...
Assent Compliance
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
Maria Cecilia Tami and Balajee Shanmugam review the Chemistry, Manufacturing and Controls (CMC) portion of a drug intended for use under an ...
U.S. Food and Drug Administration
Selected Case Studies and Impurity Strategies for Drug Substances Part I: Introduction to PGIs
Regis' Director of Analytical Method Development, Dr. Paul Wrezel, repurposes his Pittcon 2015 talk for a Regis audience. In this first part of three, he gives an ...
Regis Technologies, Inc.
Inside Italy's Secret Toxic Waste Crisis
Toxic Secret (2014): On the foothills of Mount Vesuvius a new threat has emerged. Known as the "triangle of death"; For similar stories, see: The Mafia Are Still ...
Journeyman Pictures
Cancer Revealed: How the Immune System Sees and Destroys Tumors, with Jeffrey Weber
On June 16, 2015, Jeffrey S. Weber, M.D., Ph.D., discussed the cancer immunity cycle and the importance of antigen release and presentation to maximize the ...
Cancer Research Institute
